CAFs and TGF-β Signaling Activation by Mast Cells Contribute to Resistance to Gemcitabine/Nabpaclitaxel in Pancreatic Cancer.
CAFs and TGF-β Signaling Activation by Mast Cells Contribute to Resistance to Gemcitabine/Nabpaclitaxel in Pancreatic Cancer. — المؤلف: Porcelli, Letizia — Cancers Mar 2019
- المؤلف
- Porcelli, Letizia
- النشر
- Cancers Mar 2019